GlassScriptPhysician profile
Lorraine Lira
NPI 1649354119
$11,146.42
in general payments reported to CMS, 2019-2025
57 companies · $911 in 2025
The $911 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,483 · 2020: $1,369 · 2021: $1,703 · 2022: $2,192 · 2023: $1,670 · 2024: $1,818 · 2025: $911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,398.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $3,319.23 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Abbvie INC. | $898.24 | 2021-2025 | |
| Mdd US Operations, LLC | $486.20 | 2019-2025 | Apokyn, Xadago, Apokyn |
| Neurocrine Biosciences, INC. | $412.40 | 2019-2025 | Ingrezza, Ongentys |
| Lundbeck LLC | $402.04 | 2019-2025 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $335.81 | 2021 | |
| Novartis Pharmaceuticals Corporation | $317.78 | 2019-2024 | |
| Allergan, INC. | $277.94 | 2019-2022 | |
| Eisai INC. | $250.95 | 2019-2025 | |
| Pfizer INC. | $242.70 | 2023-2025 | |
| Emd Serono, INC. | $235.34 | 2019-2023 | Mavenclad |
| Kyowa Kirin, INC. | $232.69 | 2023-2025 | Nourianz |
| Celgene Corporation | $231.10 | 2020-2023 | Zeposia |
| Biogen, INC. | $221.41 | 2019-2023 | Vumerity, Avonex, Tysabri |
| Lilly USA, LLC | $217.90 | 2019-2024 | Emgality, Reyvow, Amyvid |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorraine Lira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.